Cosmo First's Zigly acquires Prolife Vet Clinic with ₹4.36 crore ARR

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Cosmo First's Zigly acquires Prolife Speciality Vet Clinic LLP in Mumbai
  • Clinic reports annual recurring revenue (ARR) of ₹4.36 crore
  • Transaction executed via slump sale on 'as is where is' basis
  • Facility to be transformed into 24x7 operation within 9-12 months
powered bylight_fuzz_icon
52230657

*this image is generated using AI for illustrative purposes only.

Cosmo First Ltd announced that its pet care division, Zigly, has acquired Prolife Speciality Vet Clinic LLP in Mumbai. The acquisition strengthens Zigly’s veterinary footprint and aligns with its strategy to build a comprehensive pet care ecosystem.

The Prolife Speciality Vet Clinic, operational since 2000 and managed by Dr. S. M. Gadge, treats close to 20K pets annually. It reported an annual recurring revenue (ARR) of ₹4.36 crore. The clinic offers outpatient consultations, diagnostics, surgery, endoscopy, pathology, and pharmacy services.

Strategic expansion in Mumbai

This marks the third strategic acquisition for Zigly Pet Care, following earlier purchases of Small Animal Clinic & Surgical Centre in Khar West and Dr. Santa's Pet Clinic. The company plans to transform the new facility into a 24x7 operation within the next nine to twelve months. Existing veterinary staff and support teams will remain to ensure continuity of care for current clients.

Saurabh Jain, Chief Executive Officer of Zigly Pet Care, stated that the move reflects a long-term strategy to scale high-quality veterinary services through partnerships with respected clinicians. He noted the growing demand for specialized healthcare backed by clinical expertise among Indian pet parents.

Acquisition structure and financials

The transaction was executed through a Business Transfer Agreement on an "as is where is" basis via a slump sale. Cosmo First confirmed that the deal does not constitute a related party transaction. The consideration is cash-based, structured as a lumpsum amount paid in six installments, contingent upon the seller fulfilling all obligations under the agreement. The specific cost of acquisition remains undisclosed due to confidentiality clauses.

The acquisition includes all assets and liabilities, brand name, goodwill, social media handles, backend software licenses, employee contracts, supplier agreements, and the entire customer database. Regulatory approvals are not required for this specific business transfer.

What the numbers show

The acquisition adds a high-revenue, established practice to Zigly’s network. With an ARR of ₹4.36 crore from a single location treating approximately 20,000 pets, the clinic demonstrates strong unit economics and customer retention over two decades. Integrating this facility allows Zigly to leverage existing infrastructure while expanding service hours to 24x7, potentially increasing revenue per square foot without significant greenfield capital expenditure.

A closer look at the historical turnover reveals a significant inflection point in recent years. While the clinic maintained steady revenues of ₹0.83 crore in both FY24 and FY25, it recorded a substantial jump to ₹1.95 crore in FY26. This more than doubling of turnover in the most recent fiscal year suggests accelerating demand or operational improvements prior to the acquisition, enhancing the asset's value proposition for Zigly.

Historical Stock Returns for Cosmo First

1 Day5 Days1 Month6 Months1 Year5 Years
-0.94%-3.65%-11.04%+40.29%-1.75%-12.07%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

How will the undisclosed cash consideration impact Cosmo First's near-term liquidity and capital allocation strategy?

What specific operational milestones must Zigly meet to successfully transition the clinic to a 24x7 model within the 9-12 month timeline?

Can Zigly replicate the recent revenue inflection seen at Prolife across its other acquired clinics through similar integration strategies?

Cosmo First to host investor meet at Aurangabad plant on Sep 23

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Cosmo First to host investors at Aurangabad plant
  • Meeting scheduled for September 23, 2026, at 3:30 pm
  • No UPSI will be disclosed during the tour
powered bylight_fuzz_icon
51279048

*this image is generated using AI for illustrative purposes only.

Cosmo First Limited will host analysts and investors at its Aurangabad plant on Wednesday, September 23, 2026, at 3:30 pm. The visit is scheduled pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

The company stated that no confidential or unpublished price-sensitive information (UPSI) will be disclosed during the plant tour. The schedule remains subject to change in case of exigencies involving the investors or analysts.

Jyoti Dixit, Company Secretary and Compliance Officer, issued the intimation on September 18, 2026. The disclosure was filed with both the BSE Limited and the National Stock Exchange of India Ltd.

Historical Stock Returns for Cosmo First

1 Day5 Days1 Month6 Months1 Year5 Years
-0.94%-3.65%-11.04%+40.29%-1.75%-12.07%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

How might the operational insights shared during the Aurangabad plant visit influence Cosmo First's near-term production capacity forecasts?

What impact could this investor engagement have on institutional sentiment and stock liquidity in the weeks following the tour?

Are there any upcoming regulatory changes in the packaging sector that this plant visit aims to address or prepare investors for?

More News on Cosmo First

1 Year Returns:-1.75%